Shashank Cingam (@Shashankcingam) profile picture

BBMT/CellTherapy Physician @ Ochsner-LSU FWCC | Fellowship @StanfordBMT_CT|Tweets, RT’s are personal opinions and not endorsements

Albuquerque, NM
Joined January 2017
Photo by Shashank Cingam (@Shashankcingam)Photo by Shashank Cingam (@Shashankcingam)Photo by Shashank Cingam (@Shashankcingam)Photo by Shashank Cingam (@Shashankcingam)
Shashank Cingam retweeted
Thanks @US_FDA for co-hosting the FDA-ASH Workshop! The past two days, participants explored the FDA’s role in #hematology product development through panels and case discussions, fostering dialogue on key regulatory issues. ow.ly/4io250X4yoc #HemeOnc @FDAOncology
1
6
3
20
4,711
It’s #ASHCRTI week in LaJolla. @ASH_hematology A week full of redoing study proposals, mentorship and forming life long professional friendships for participants and faculty - 28 trainees across classical and malignant hematology #ASHTrainee
1
13
1
47
4,977
Management recommendations for kidney transplantation in patients with plasma cell dyscrasia - Kidney International kidney-international.org/art…
10
19
1,391
Dr.Sindhu Devarashetty @LSUHS presenting updates on Ovarian Cancer #BestofASCO2025 @binaytara #Shreveport
1
4
328
Dr. Yu Cao @utswcancer presenting updates on Head and neck cancer #BestofASCO2025 @binaytara #Shreveport
1
154
Dr.Marc Matrana @OchsnerHealth kicks-off the Best of ASCO 2025 in Shreveport #BestofASCO2025 #Shreveport @binaytara
1
4
337
Dr.Brian Halbert @OchsnerHealth presenting updates in Baldder Cancer at #BestofASCO2025 @binaytara #Shreveport
1
3
283
Dr.Dalia Hammoud presents on updates prostate cancer #BestofASCO2025 #Shreveport @binaytara @LSUHS
1
4
329
“Nonclassical” myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms represent a heterogeneous group of malignancies characterized by a wide range of clinical manifestations. ow.ly/5knJ50W1ftQ #myeloidneoplasia #transplantation
1
19
50
4,482
#ASCO25 Looking forward to seeing CARTITUDE-1 long term presentation shortly! #mmsm 1 in 3 (32/97) patients alive and progression-free for ≥5 years - functional cure in my opinion. Simultaneous JCO pub, highlighted NY Times ascopubs.org/doi/10.1200/JCO… nytimes.com/2025/06/03/healt…
2
12
2
58
6,042
Shashank Cingam retweeted
Dr. Punita Grover @UMNews showing ⬆️ chronic #GVHD with #PTCy/siro/MMF vs PTCy/tac/MMF in a sequential phase II well matched myeloablaive study setting ⚡️#Tandem25
7
23
3,088
Shashank Cingam retweeted
International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma | Leukemia nature.com/articles/s41375-0…
4
40
5
120
21,464
An very important white paper summarizing thoughts from different stakeholders including academia, FDA, and others from a workshop that debated every aspect of Drug Development in #MDSsm kudos to authors led by myeloid malignancy rising star @dralainmina ashpublications.org/bloodadv…
1
9
1
34
2,952
Audrey is immensely supportive. She is a constant and eager pool of information and institutional knowledge. She steps in immediately to cover her teammates' patients. She was able to help two new hires with grace and kindness.
1
3
177
Honored to have delivered our abstract as an oral presentation at ASH '24. Teclistamab can be given safely and effectively in the community bringing the drug more directly to the patients who need it! @HealthTree @AimazAfrough @utswcancer @ldandersonjr @flatironhealth
1
8
28
1,785
Shashank Cingam retweeted
Say it with me: 'Arlo-cel' - GPRC5D -directed CAR T presented by @SusanBal9 We see a very high ORR (91%) at the 150 x 10^6 dose. mPFS of 18 months Skin, nail, taste changes seem less, and less prolonged. There is a known neurotoxicity (12% all grades, 7% grade 3-4) characterized by dizziness, ataxia, nystagmus, and/or dysarthria. #ASH24
2
19
1
42
5,562
Shashank Cingam retweeted
#ASH24 Impressive real-world data from the Greek myeloma group suggesting that sustained MRD negativity for 3 years can guide discontinuation of lenalidomide maintenance, probably except in patients with +2 high risk cytogenetics. #mmsm @thanosdimop
2
34
7
88
7,436